Insider · CIK 0001379218

Vander Vort John

CIK 0001379218 Name as filed on the most recent filing

Filed as Vander Vort John (18)

29 transaction lines · from 18 filings · filed 2007-01-05 to 2015-03-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

2 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-03-06 S, Open-market sale Aratana Therapeutics, Inc.PETX 122,776, disposed Open Form 4 filing 0001209191-15-023723
2013-07-30 P, Open-market purchase Conatus Pharmaceuticals IncCNAT 1,817,915, acquired Open Form 4 filing 0001209191-13-038629
2013-07-02 P, Open-market purchase Aratana Therapeutics, Inc.PETX 3,000,000, acquired Open Form 4 filing 0001209191-13-034986
2013-03-11 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 13,930,000, disposed Open Form 4 filing 0001209191-13-016170
2012-02-01 P, Open-market purchase Verastem, Inc.VSTM 1,000,000, acquired Open Form 4 filing 0001209191-12-007620
2011-11-21 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 2,999,997, acquired Open Form 4 filing 0001209191-11-057585
2011-02-08 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 2 lines 3,749,998, acquired Open Form 4 filing 0001209191-11-010540
2009-02-12 P, Open-market purchase Peplin IncPLIN 10,242, acquired Open Form 4 filing 0001209191-09-008572
2009-02-11 P, Open-market purchase Peplin IncPLIN 7,992, acquired Open Form 4 filing 0001209191-09-008572
2009-02-09 P, Open-market purchase Peplin IncPLIN 7,992, acquired Open Form 4 filing 0001209191-09-007923
2009-02-05 P, Open-market purchase Peplin IncPLIN 20,654, acquired Open Form 4 filing 0001209191-09-007153
2009-01-27 P, Open-market purchase Peplin IncPLIN 2 lines 13,716, acquired Open Form 4 filing 0001209191-09-005046
2009-01-23 P, Open-market purchase Peplin IncPLIN 48,232, acquired Open Form 4 filing 0001209191-09-005046
2009-01-22 P, Open-market purchase Peplin IncPLIN 2 lines 20,914, acquired Open Form 4 filing 0001209191-09-004708
2009-01-21 P, Open-market purchase Peplin IncPLIN 7,456, acquired Open Form 4 filing 0001209191-09-004708
2009-01-20 P, Open-market purchase Peplin IncPLIN 378, acquired Open Form 4 filing 0001209191-09-003975
2009-01-19 P, Open-market purchase Peplin IncPLIN 7,372, acquired Open Form 4 filing 0001209191-09-003975
2009-01-16 P, Open-market purchase Peplin IncPLIN 60,188, acquired Open Form 4 filing 0001209191-09-003975
2009-01-15 P, Open-market purchase Peplin IncPLIN 12,464, acquired Open Form 4 filing 0001209191-09-003975
2009-01-13 P, Open-market purchase Peplin IncPLIN 48,584, acquired Open Form 4 filing 0001209191-09-003416
2007-09-14 S, Open-market sale Memory Pharmaceuticals CorpMEMY 57,960, disposed Open Form 4 filing 0001209191-07-053964
2007-09-13 S, Open-market sale Memory Pharmaceuticals CorpMEMY 132,120, disposed Open Form 4 filing 0001209191-07-053453
2007-09-12 S, Open-market sale Memory Pharmaceuticals CorpMEMY 21,611, disposed Open Form 4 filing 0001209191-07-053453
2006-12-18 P, Open-market purchase Memory Pharmaceuticals CorpMEMY 2,569,818, acquired Open Form 4 filing 0001181431-07-002395

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Vander Vort John, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001379218

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.